The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.
Fig 1. Summary of key recommendations. ALN, axillary lymph node; ALND, axillary lymph node dissection; CDK, cyclin-dependent kinase; cm, centimeter; H, high; HER2 ...
MedPage Today on MSN
No Survival Dip After Skipping Axillary Surgery for Locally Advanced Breast Cancer
Applies to most patients with one or two positive sentinel lymph nodes ...
Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...
Trends and outcomes in patients receiving neoadjuvant chemotherapy for breast cancer in Ontario: A population-based study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Apollo Hospitals Chennai Performs World's First Robotic Cancer Surgery for Lymph Node Removal Using Hugo RAS Platform via ...
MedPage Today on MSN
No prostate cancer survival benefit with more extensive lymph node assessment
Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...
N1 Single lymph node metastasis, 2 cm or less in greatest dimension N1 Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node) N2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results